Indonesia Drug Makers Said Harmed By API Lack, Weak Generics Support
This article was originally published in PharmAsia News
Executive Summary
Indonesia’s growth potential in the pharmaceuticals market is being hampered by a range of issues, including its lack of local raw materials and a complicated registration process.